These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3909077)

  • 1. [Metabolism of antipyrine in man].
    Pautet F; Barret R; Daudon M; Mathian B
    Pathol Biol (Paris); 1985 Sep; 33(7):777-80. PubMed ID: 3909077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the diethylamide of nicotinic acid (cordiamine) on the hydroxylating function of the liver].
    Bushma MI; Zavodnik LB; Lukienko PI
    Farmakol Toksikol; 1989; 52(4):56-9. PubMed ID: 2806530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of silybin on the hepatic microsomal drug-metabolising enzyme system in the rat.
    Down WH; Chasseaud LF; Grundy RK
    Arzneimittelforschung; 1974 Dec; 24(12):1986-8. PubMed ID: 4218108
    [No Abstract]   [Full Text] [Related]  

  • 4. Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes.
    Iribarne C; Berthou F; Baird S; Dréano Y; Picart D; Bail JP; Beaune P; Ménez JF
    Chem Res Toxicol; 1996 Mar; 9(2):365-73. PubMed ID: 8839037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
    Labroo RB; Paine MF; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 5-fluorouracil on drug-metabolizing enzymes in the rat.
    Klubes P; Cerna I
    Cancer Res; 1974 May; 34(5):927-31. PubMed ID: 4823903
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipyrine metabolism in the rat by three hepatic monooxygenases.
    Inaba T; Lucassen M; Kalow W
    Life Sci; 1980 Jun; 26(23):1977-83. PubMed ID: 7401910
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of clarithromycin and its metabolites on the mixed function oxidase system in hepatic microsomes of rats.
    Ohmori S; Ishii I; Kuriya S; Taniguchi T; Rikihisa T; Hirose S; Kanakubo Y; Kitada M
    Drug Metab Dispos; 1993; 21(2):358-63. PubMed ID: 8097709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of p(4')-hydroxyantipyrine as a metabolite of antipyrine in man.
    Inaba T; Uchino H; Kalow W
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):3-8. PubMed ID: 7268206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perinatal drug metabolism and morphological changes in the hepatocytes of normal and phenobarbital-treated guinea pigs.
    Kuenzig W; Kamm JJ; Boublik M; Jenkins F; Burns JJ
    J Pharmacol Exp Ther; 1974 Oct; 191(1):32-44. PubMed ID: 4153895
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic microsomal drug metabolism, glutamyl transferase activity and in vivo antipyrine half-life in rats chronically fed an ethanol diet, a control diet and a chow diet.
    Gadeholt G; Aarbakke J; Dybing E; Sjöblom M; Mørland J
    J Pharmacol Exp Ther; 1980 Apr; 213(1):196-203. PubMed ID: 6102148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of various barbiturates on hepatic microsomal enzymes. A comparative study.
    Valerino DM; Vesell ES; Aurori KC; Johnson AO
    Drug Metab Dispos; 1974; 2(5):448-57. PubMed ID: 4156308
    [No Abstract]   [Full Text] [Related]  

  • 15. [Enhanced drug hydroxylation in man under diphenyl-hydantoin therapy].
    Petruch F; Schüppel RV
    Arzneimittelforschung; 1974 Jul; 24(7):1023-5. PubMed ID: 4211429
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between metabolic clearance rate of antipyrine and hepatic microsomal drug-oxidizing enzyme activities in humans without liver disease.
    Vuitton D; Miguet JP; Camelot G; Delafin C; Joanne C; Bechtel P; Gillet M; Carayon P
    Gastroenterology; 1981 Jan; 80(1):112-8. PubMed ID: 7450397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the thromboxane synthetase inhibitor Dazoxiben (UK 37-248) on the metabolism of antipyrine in patients with enhanced platelet aggregation.
    Staiger C; Walter E; Wang NS; Schuhmacher E; de Vries J; Weber E
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):250-3. PubMed ID: 6540249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine.
    Sharer JE; Wrighton SA
    Drug Metab Dispos; 1996 Apr; 24(4):487-94. PubMed ID: 8801065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation of microsomal mixed function oxidase(s) and human lung cancer.
    Kellermann G; Jett JR; Luyten-Kellermann M; Moses HL; Fontana RS
    Cancer; 1980 Mar; 45(6):1438-42. PubMed ID: 7357525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic interactions of putative cytochrome P4503A substrates with alternative pathways of dapsone metabolism in human liver microsomes.
    Irshaid Y; Branch RA; Adedoyin A
    Drug Metab Dispos; 1996 Feb; 24(2):164-171. PubMed ID: 8742227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.